Tissue & Cell Technologies

Studies

CLINICALLY DRIVEN

We are clinically driven at T&CT, and medical evidence lies at the heart of everything we do.

Our technology, commercial services, and products have been extensively tested and subjected to independent external validation. Take a look at some of our current and past studies below…

multi-center large volume reconstructive surgery study

University of Pittsburgh Medical Center (Pittsburgh, PA), Washington University Medical Center (St. Louis, MO), The Sorbonne Medical School (Paris, FR)

Autologous Stem Cell-based Wound Healing Therapeutics

University of Sheffield Click Here

Wellcome MRC Cambridge Stem Cell Institute

Heart muscle patch Click Here

Wellcome MRC Cambridge Stem Cell Institute

Broad-ranging collaboration Click Here

MULTI-CENTER SAFETY & EFFICACY STUDY FOR THE USE OF STORED AUTOLOGUS FAT IN BREAST RECONSTRUCTION

2014-2016

Nottingham University Hospital NHS Trust

‘Healthcare Evaluation of Cost-Effectiveness and PROMs of ADIPOSET Fat Storage System Versus Standard Care for Fat Grafting Procedure in Breast Reconstruction,’ 2019- Lead Investigator: Mr. Douglas Macmillan Click Here

Clinica San Francesco, Verona & Univ of Verona, Italy

‘Investigating the biological mechanisms involved in stored fat-enabled Rigottomy procedures,’ 2021/2022 Lead Investigators: Dr. Gino Rigotti and Professor Andrea Sbarbati Click Here

T&CT & University of Bradford

‘Developing the First Standardised, Adipose-Derived Regenerative Therapies for Personalised Medicine,’ 2020/2021 Lead Investigators: Dr. David Haddow and Dr. Julie Thornton Click Here

Guys and St Thomas's NHS Foundation Trust

‘Study into the outcomes of using cryopreserved adipose tissue for lipo-filling in breast reconstruction when compared to standard practice using freshly harvested tissue,’ 2020-; Lead Investigator: Ms. Pari-Naz Mohana Click Here

Oxford University Hospitals (John Radcliffe Hospital) NHS Trust

‘Study Into the Outcomes of Using Cryopreserved Autologous Tissue for Corrective or Revision Plastic Surgery Applications in Breast Surgery’ 2020-; Lead Investigator: Mr. Peter Kalu Click Here

North Tees and Hartlepool NHS Foundation Trust

‘A Pilot Study to Determine the Safety and Efficacy of Autologous Adipose Tissue Banking in Breast Reconstruction Following Cancer,’ 2017 – Concluded // Lead Investigators: Mr. Pud Bhaskar (North Tees) & and Ms. Eva Weiler-Mithoff (Glasgow Royal Infirmary)
Click Here
We are clinically driven at T&CT, and medical evidence lies at the heart of everything we do.
Our technology, commercial services, and products have been extensively tested and subjected to independent external validation.

Multi-Center large volume reconstructive surgery study - University of Pittsburgh Medical Center (Pittsburgh), Washington University Medical Center (St Louis), The Sorbonne Medical School (Paris)

Autologous Stem Cell-based Wound Healing Therapeutics – University of Sheffield
Wellcome MRC Cambridge Stem Cell Institute – heart muscle patch

Wellcome MRC Cambridge Stem Cell Institute – broad-ranging collaboration

Multi-center safety & efficacy study for the use of stored autologous fat in breast reconstruction (2014-2016)

Wellcome MRC Cambridge Stem Cell Institute – broad-ranging collaboration

Nottingham University Hospital NHS Trust

‘Healthcare Evaluation of Cost-Effectiveness and PROMs of Adiposet Fat Storage System Versus Standard Care for Fat Grafting Procedure in Breast Reconstruction, ‘2019- Lead Investigator: Mr. Douglas Macmillan

Clinica San Francesco, Verona & Univ of Verona, Italy

‘Investigating the biological mechanisms involved in stored fat-enabled Rigottomy procedures,’ 2021/2022 Lead Investigators: Dr. Gino Rigotti and Professor Andrea Sbarbati

T&CT & University of Bradford

‘Developing the First Standardised, Adipose-Derived Regenerative Therapies for Personalised Medicine,’ 2020/2021 Lead Investigators: Dr. David Haddow and Dr. Julie Thornton

Guys and St Thomas's NHS Foundation Trust

‘Study into the outcomes of using cryopreserved adipose tissue for lipo-filling in breast reconstruction when compared to standard practice using freshly harvested tissue,’ 2020-; Lead Investigator: Ms. Pari-Naz Mohana

Oxford University Hospitals (John Radcliffe Hospital) NHS Trust

‘Study Into the Outcomes of Using Cryopreserved Autologous Tissue for Corrective or Revision Plastic Surgery Applications in Breast Surgery’ 2020-; Lead Investigator: Mr. Peter Kalu

North Tees and Hartlepool NHS Foundation Trust

‘A Pilot Study to Determine the Safety and Efficacy of Autologous Adipose Tissue Banking in Breast Reconstruction Following Cancer,’ 2017 – Concluded Lead Investigators: Mr. Pud Bhaskar (North Tees) & and Ms. Eva Weiler-Mithoff (Glasgow Royal Infirmary)
Scroll to Top

Development Pipelines & Future Sectors

We are partnering and collaborating with leaders and research groups worldwide who have promising long-term applications and therapeutics in regenerative medicine, cell-based therapies, and personalized medicine.


All major cell types, including muscle, heart, pancreas, hair, skin, cartilage, and more. We want our technology to help pave the way for full organ regeneration, organoids, and other rejuvenation therapies.

Aesthetic

plastic surgery including reprioritize BBL, breast augmentation, injectables, and skin rejuvenation

Our technology offers a natural and safe solution for aesthetic procedures. The volumizing and self-healing properties of a patient’s own fat and stems cells are already well recognized in plastic surgery.

With significantly lower or no risk of complications, our technology ensures that no artificial compounds or toxins are introduced into the human body, providing a safe and natural solution for patients.

Reconstructive

Breast reconstruction, reconstructive surgery, and similar applications

Fat has been used for over 30 years, and the benefits of storage for all stakeholders, particularly patients, are enormous and potentially life-changing.